2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Mumps: new trials by email Literature Review of Mumps trials Research Report on Mumps
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination MMR booster vaccination (as M-M-R-VaxPro) - Mumps, Measles | Phase 3 | Unknown | University of Zurich | 200 | 2023-12-01 | 2024-01-08 |
| Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11 Attenuated Mumps vaccine (KMB-17) in phase II and III, Placebo in phase II, Attenuated Mumps vaccine (KMB-17) in phase III - Epidemic Parotitis, Mumps | Phase 2 / Phase 3 | Unknown | Institute of Medical Biology, Chinese Academy of Medical Sciences | 11999 | 2020-10-12 | 2023-10-11 |
Infections (2) · Mononegavirales Infections (2) · Mouth Diseases (2) · Paramyxoviridae Infections (2) · Parotid Diseases (2) · Parotitis (2) · RNA Virus Infections (2) · Rubulavirus Infections (2) · Salivary Gland Diseases (2) · Stomatognathic Diseases (2) · Virus Diseases (2) · Morbillivirus Infections (1) · Rubivirus Infections (1) · Togaviridae Infections (1)
Clinical Trials, Phase II as Topic (1) · Clinical Trials, Phase III as Topic (1)
Institute of Medical Biology, Chinese Academy of Medical Sciences (1) · University of Zurich (1)
China (1) · Switzerland (1)
Jan Fehr, M.D. (1) · Qihan Li (1)